Literature DB >> 3282566

Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase.

C K Arthur1, J F Apperley, A P Guo, F Rassool, L M Gao, J M Goldman.   

Abstract

Forty-eight patients treated by allogeneic bone marrow transplantation (BMT) for Philadelphia (Ph) chromosome-positive chronic myeloid leukemia in chronic phase had serial cytogenetic studies of marrow performed at intervals after transplant. Twenty patients received marrow cells from donors of opposite sex. Ph+ marrow metaphases were identified in 24 of 48 (50%) of patients after BMT; they were first seen early (within 1 year) in 16 cases and late (greater than 1 year after BMT) in eight cases. Ph-positivity after BMT occurred more commonly in recipients of T-depleted than nondepleted marrow (19 of 28 v 5 of 20). In 4 cases the Ph+ metaphases were found only transiently after BMT; in 11 cases the Ph+ metaphases have persisted but hematologic relapse has not ensued; in 9 cases the finding of Ph+ metaphases coincided with or preceded hematologic relapse. Chromosomes in cells of donor origin had morphological abnormalities in two cases. No relapses were identified in cells of donor origin. Our data suggest that the relationship between cells of recipient and donor origin is complex: cure of leukemia may depend on factors that operate for some months or years after BMT.

Entities:  

Mesh:

Year:  1988        PMID: 3282566

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Molecular biology in medicine.

Authors:  B D Young
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 2.  An overview of bone marrow transplantation for chronic myeloid leukemia.

Authors:  M J Barnett; A C Eaves; G L Phillips
Journal:  CMAJ       Date:  1990-08-01       Impact factor: 8.262

Review 3.  Bone marrow transplantation. Part I--Allogeneic.

Authors:  N J Chao; K G Blume
Journal:  West J Med       Date:  1989-12

4.  Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.

Authors:  C L Sawyers; L Timson; E S Kawasaki; S S Clark; O N Witte; R Champlin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction.

Authors:  Vivian G Oehler; Jerald P Radich
Journal:  Curr Hematol Malig Rep       Date:  2006-09       Impact factor: 3.952

6.  Clonal expansion after bone marrow transplantation in a patient with chronic myelogenous leukemia.

Authors:  M J Macera; A C Botti; R S Verma; M Coleman; E D Thomas
Journal:  Blut       Date:  1988-11

7.  Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia.

Authors:  O G Jonsson; R L Kitchens; R J Baer; G R Buchanan; R G Smith
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 8.  Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia.

Authors:  Vivian G Oehler; Jerald P Radich
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

9.  Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.

Authors:  D P Agaliotis; P R Papenhausen; L C Moscinski; G J Elfenbein
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673

10.  JC polyomavirus infection in candidates for kidney transplantation living in the Brazilian Amazon region.

Authors:  Fernando Assis Ferreira Melo; Ana Caroline Fonseca Bezerra; Bárbara Brasil Santana; Marluísa Oliveira Guimarães Ishak; Ricardo Ishak; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.